Filter by
Filter by
Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.
This study from Taiwan retrospectively examined 30 patients with unresectable CC who were treated with PBT to a total dose of 72.6 GyRBE. The 1-year local...
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.
Published in JCO (Journal of Clinical Oncology), this randomized trial compared total toxicity burden (TTB) and progression-free survival (PFS) between PBT and...
Proton Beam Therapy Is a Safe and Effective Treatment in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESCC).
This study from Japan reported results of 54 esophageal cancer patients who are over 75 years old treated with PBT. 38 inoperable patients (70.4%) and 16...
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
Published by the NCC group in Korea, this study reported outcomes of 45 patients including 37 had recurrent and/or residual disease treated with PBT to a total...
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase trial.
This randomized study compared PBT and radiofrequency ablation (RFA) for patients with recurrent/residual HCC. The local progression free survival values of PBT...